Φορτώνει......
Acute severe liver dysfunction induced by febuxostat in a patient undergoing hemodialysis
A 58-year-old man with chronic kidney disease (CKD) was admitted to our hospital for hemodialysis (HD) therapy. He had been administered allopurinol (100 mg/day) before hospitalization, and we replaced it with febuxostat (10 mg/day), a new xanthine oxidase inhibitor. Levels of aspartate aminotransfe...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | CEN Case Rep |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Springer Japan
2014
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5411563/ https://ncbi.nlm.nih.gov/pubmed/28509193 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13730-014-0109-2 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|